Occupational Therapists in Brandon, SD Accepting Medicare
6 Occupational Therapists found. Showing 1 - 6
 Amy Lynn Mutschelknaus, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 48371 265th St, Brandon, SD 57005 Phone: 605-582-7716 |
Mrs. Julie R Wooters, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 217 Country Club Ave, Brandon, SD 57005 Phone: 605-582-8421 |
Kelcey Smith, OTD, OTR/L Occupational Therapist - Physical Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2301 E Oak Hill Cir, Brandon, SD 57005 Phone: 605-212-6008 |
Annlee Ralston, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 300 S Splitrock Blvd, Brandon, SD 57005 Phone: 605-582-3446 Fax: 605-582-3229 |
Melissa Rogers Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1220 E Holly Blvd, Brandon, SD 57005 Phone: 605-582-3103 |
Karla Karrin Jorgenson, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 103 North Splitrock Blvd, Brandon, SD 57005 Phone: 605-582-3908 Fax: 605-582-3349 |
News Archive
Blood vessels grown from pluripotent stem cells able to function inside mice
Researchers at Johns Hopkins have coaxed stem cells into forming networks of new blood vessels in the laboratory, then successfully transplanted them into mice. The stem cells are made by reprogramming ordinary cells, so the new technique could potentially be used to make blood vessels genetically matched to individual patients and unlikely to be rejected by their immune systems, the investigators say.
Ancient East Asian peoples may have adapted to coronavirus-like epidemic up to 25,000 years ago
A new study by researchers at the University of Adelaide and Australian National University in Australia and the University of Arizona in the US shows that an ancient coronavirus-like epidemic drove the adaptation of East Asian peoples from 25,000 to 5,000 years ago.
Tolera Therapeutics granted orphan drug status for organ transplant rejection lead candidate drug
Tolera Therapeutics, Inc., was granted orphan drug status by the United States Food and Drug Administration (FDA) for its initial lead candidate, TOL101, for prophylaxis of acute rejection of solid organ transplantation.
Existing drugs may be useful in treating brain tumors
Scientists have shown how developing brain tumors can turn an encounter with a signaling molecule from a fatal experience for the tumor cells into a cue for their own growth and multiplication.
› Verified 4 days ago
Chiropractors
Speech-Language Pathologists
Physical Therapists
Occupational Therapists
Optometrists